Medical Device Industry News | BioSpace
Avinger, Inc. announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. into a shares of a new series of convertible preferred stock.
XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its smart steerable guidewires and robotic systems, successfully completed a first-of-its-kind live telerobotic trial for stroke treatment between Abu Dhabi and South Korea at Abu Dhabi Global Healthcare Week.
NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, issued a letter to its stockholders from its Chief Executive Officer, Brian Murphy, providing a review of the first quarter of 2024 and recent business developments.
This announcement summarizes Bioretec Ltd's business review for January-March 2024.
INVO Bioscience, Inc. announced financial results for the first quarter of 2024 and provided a business update.
Avinger, Inc., a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, reported results for the first quarter ended March 31, 2024.
Vytvořte si vlastní zdroj
Jste připraveni to vyzkoušet?
Spusťte 14denní zkušební verzi bez nutnosti platební karty.